Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Neurological Sciences

• Publication date

  1987-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-510X(87)90022-0PMID 3440867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.

  1986cited by this paper
• Identification of M2 muscarinic receptors in membranes from bovine cerebral basal arteries.

  1986cited by this paper
• Molecular distinction between calf heart and brain muscarine receptors: different N-ethylmaleimide modulation of agonist binding.

  1986cited by this paper
• Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

  1985cited by this paper
• Different effects of N-ethylmaleimide on M1 and M2 muscarine receptors in rat brain.

  1985cited by this paper
• Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.

  1985cited by this paper
• Regional Differences in the Coupling of Muscarinic Receptors to Inositol Phospholipid Hydrolysis in Guinea Pig Brain

  1985cited by this paper
• Regional and Cortical Laminar Distributions of Serotonin S2, Benzodiazepine, Muscarinic, and Dopamine D2 Receptors in Human Brain

  1984cited by this paper
• A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart

  1984cited by this paper
• Topography of the Magnocellular Basal Forebrain System in Human Brain

  1984cited by this paper
• Evidence for Multiple Muscarinic Receptor Subtypes in Human Brain

  1984cited by this paper
• Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.

  1984cited by this paper
• A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.

  1983cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Immunohistochemical staining of the human forebrain with monoclonal antibody to human choline acetyltransferase.

  1983cited by this paper
• Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

  1983cited by this paper
• The organization and some projections of cholinergic neurons of the mammalian forebrain.

  1982cited by this paper
• Cortical muscarinic receptor subtypes and Alzheimer's disease.

  1982cited by this paper
• Pre- and postsynaptic muscarinic receptors in surgical samples from human cerebral cortex.

  1982cited by this paper
• Muscarinic cholinergic receptor sites in cerebral blood vessels.

  1982cited by this paper
• [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.

  1982cited by this paper
• Muscarinic receptor: regulation by guanine nucleotides, ions, and N-ethylmaleimide.

  1981cited by this paper
• Axoplasmic transport of muscarinic receptors

  1980cited by this paper
• Pirenzepine distinguishes between different subclasses of muscarinic receptors

  1980cited by this paper
• CHARACTERIZATION AND SUBCELLULAR LOCALIZATION OF BRAIN MUSCARINIC RECEPTORS LABELLED IN VIVO BY [3H]DEXETIMIDE

  1979cited by this paper
• Guanine nucleotides modulate muscarinic receptor binding in the heart.

  1979cited by this paper
• The binding of agonists to brain muscarinic receptors.

  1978cited by this paper
• The binding of antagonists to brain muscarinic receptors.

  1978cited by this paper
• Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. Part II. Binding of (plus)-benzetimide, (minus)-benzetimide and atropine to a fraction from bovine tracheal smooth muscle and to bovine caudate nucleus.

  1974cited by this paper
• Muscarinic cholinergic binding in rat brain.

  1974cited by this paper

• Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance

  2021cites this paper
• Cyto- and receptor architectonic mapping of the human brain.

  2018cites this paper
• University of Groningen Muscarinic Cholinoceptive Neurons in the Frontal Cortex in Alzheimer ’ s Disease

  2017cites this paper
• Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer’s disease

  2017cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia.

  2006cites this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cites this paper
• Effect of some phenothiazine and dibenzazepime derivatives on the muscarinic cholinergic system

  2004cites this paper
• Assessment of neuroreceptor changes in healthy ageing and in Alzheimer's disease with emission tomography

  2003cites this paper
• Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia

  2000cites this paper
• Chapter V The cholinergic system in the primate brain: basal forebrain and pontine-tegmental cell groups

  1997cites this paper
• Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease

  1997cites this paper
• Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.

  1997cites this paper
• The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

  1996cites this paper
• New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia

  1996cites this paper
• Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.

  1995cites this paper
• Muscarinic M1 receptor mediated inhibition of GABA release from rat cerebral cortex.

  1994cites this paper
• In the search for a novel class of antipsychotic drugs: preclinical pharmacology of FG5803, a 1-piperazinecarboxamide derivative.

  1994cites this paper
• Muscarinic cholinoceptor subtypes in the rat frontoparietal cortex after ipsilateral lesions of the nucleus basalis magnocellularis.

  1993cites this paper
• Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia

  1992cites this paper
• Neuroreceptor changes in Alzheimer disease.

  1992cites this paper
• High-affinity choline uptake and muscarinic receptors in rat brain during aging.

  1992cites this paper
• Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease.

  1991cites this paper
• Neurotransmitters, neuroreceptors and aging.

  1991cites this paper
• Scopolamine intoxication as a model of transient global amnesia.

  1991cites this paper
• Cholinergic receptors in human brain: Effects of aging and alzheimer disease

  1990cites this paper
• Receptor binding properties of amperozide.

  1990cites this paper
• Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types

  1990cites this paper
• Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists.

  1990cites this paper
• Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases.

  1989cites this paper
• The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer.

  1989cites this paper
• D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals.

  1989cites this paper
• The Cholinergic Receptor System in the Frontal Lobe of Alzheimer Patients

  1988cites this paper